Diefreeandsell Posted - 1 month ago

@SlapSoHard i think they like the bo target to have a decent cash hoard. case in point $MRK aquisition of ph2 co $RXDX did fund raise of 500 mil run by GS and 2 months later bo. now gs and friends doing 600 mil raise for $MDGL . so def doesn’t hurt if co has some cash when acquired .

Diefreeandsell Posted - 1 month ago

$MDGL Last time gs was involved in an offering of 500 mill was with co called Prometheus bio $RXDX and shortly after that and promo piece on mad money co was bo by $MRK . Can lightning strike again for a co with fda approved drug?

Longterm_Holder2024 Posted - 1 month ago

$BPTH looks like something good is on its way. $PHUN $AMLX $RXDX $HOLO

Diefreeandsell Posted - 1 month ago

@DirtyLyle_ANY_BP_7B too many example like $SLNO $ICU $MDGL $RXDX some defy gravity like mdgl (first over mash finish line) rxdx got bo…

HighLine Posted - 1 month ago

$IOVA been watching this one…institutional ownership…stock offering that was supposed to tank the stock…buyout coming…remember $RXDX 🤔

DharlMorey2 Posted - 1 month ago

$ATOS (Spread the word) There are going to be so many bear posts that are fun to quote later on. We got 4 weeks until data at one of the biggest cancer conferences (AACR -- 20,000 [1]). They aren't going there to tell them that Z-Endoxifen failed. - 80mg coming up in less than 3 months time (1H of 2024 [2]) - I-Spy 2 phase-2 trials done in 2H of 2024 (20 patient study in innovative I-Spy trials [2]) - phase-2 MBD done in 2H of 2024 (240 patient, study) - Buyback of 10 million (1.4 million used last quarter) - Russell Inclusion 3000 and/or 2000 is looking good as long as we stay over 1.00 -- regardless, if we stay over 100 million other indices will add. - DCIS trial in progress (another phase-2) - No debt -- $94,141,000 million in cash (Do a ctrl+f for 91,141) in the bank since last filing [4] [1] https://www.abstractsonline.com/pp8/#!/20272/presentation/11540 [2] https://investors.atossatherapeutics.com/static-files/4ae72f7e-21f9-4deb-8af4-a02cff7c2dfd [3] https://classic.clinicaltrials.gov/ct2/show/NCT05868226?term=I-Spy2&draw=2&rank=2 [4] https://investors.atossatherapeutics.com/node/10721/html $CEMI $MDGL $XBI $RXDX

Diefreeandsell Posted - 1 month ago

@5xStarTrader Goldman handled the BO of $RXDX billiantly right after co had great ph2 data did an offering of 500 mil and was bought out by $mrk within 3 months. They supported price after PR pump brilliantly and handed Merck .5 bill for the BO. Pretty good if happens here!!!

Diefreeandsell Posted - 1 month ago

@Brnxbmr as example look at $RXDX before $MRK bo

Diefreeandsell Posted - 2 months ago

@boer_staf i love $TGTX and can’t wait for e’s to come out. But for now something is def going on with $LXRX and the kind of support it got yesterday after ta shows its severely overbought. Last time i saw something similar was with $rxdx before buyout.

Duboc1998 Posted - 3 months ago

$RXDX Grisly you still there bro

SnoddyTradz Posted - 4 months ago

$CCCC $MRK paid 200.00 a share for $RXDX This cancer deal in my mind is Much Bigger than that deal! Buy all you can folks!🤑

ern1in Posted - 4 months ago

$RXDX & $TGTX 🦬

Diefreeandsell Posted - 4 months ago

@PatSoonDiggler Don't do it!!! Unless knows has a deal comming with GS, like $RXDX / Prometheus Biosciences when ceo was interviewed last JAN to pump! He will say biotechs too risky before you even say co name.

BluntForceOptions Posted - 5 months ago

$VTYX $SLRN $MLTX $RXDX $MORF

TrendyChart Posted - 10/31/23

Upcoming Earnings Report: $RXDX Prometheus Biosciences will be reporting on 11/10/2023 at 4:00PM | Are you expecting earnings to be above or below expectations?

TrendyChart Posted - 6 months ago

Upcoming Earnings Report: $RXDX Prometheus Biosciences will be reporting on 10/13/2023 at 4:00PM | What's your inclination regarding earnings for this stock?

ReggieTrades Posted - 09/28/23

@BIGTEXAN409MAGA I think it'll make one big jump on news of a partnership. It'll hover at that price for a while, and then jump again on the buyout. Maybe like Prometheus $RXDX, only on a smaller scale. We'll see...

ms101 Posted - 09/28/23

$COCP Finally the true GAME-CHANGER CDI-988 molecule after 3.5 preclinical (Cocrystal is the gold standard in preclinical) which differentiates in ALL the other pre clinical small molecule biotechs who have ALL rushed and failed their COVID drug clinical trials $ENTA $PRDS $AVIR etc. Reminder Fred Hassan who purchased 1M shares, KEY board member and the PHARMA LEGEND and what ever he touches turns to gold. Last one back in April was the Merck M&A $11B $RXDX. Things are going to heat up!!

qpbeats Posted - 09/28/23

@Yalayalachabibi I want to 🩳, however I'm getting $RXDX vibes on this one...

honomo Posted - 6 months ago

@Meeks91 checkout what happened to $RXDX ...

honomo Posted - 6 months ago

@jamesjeffers check $RXDX ..check what happened to them after the pump and the offering

Diefreeandsell Posted - 7 months ago

@h8ster Only way this is sustained is if there is a buyout coming and the offering price is a tip off that there isn't one or it would have been higher. This isn't another $RXDX, no freaking way! Check out rxdx chart last Jan after their offering before buyou and GS was doing offering.

Money__ Posted - 7 months ago

@opsofjoe $RXDX $CRNX How are the Offerings similar?

macroaxis Posted - 7 months ago

$RXDX - Investment perspective on Prometheus Biosciences vs. IPG Photonics ( $IPGP ) in October 2023. Next financial report is on 8th of November 2023 https://www.macroaxis.com/competition/RXDX/IPGP/Prometheus-vs-IPG #portfolio_prospective #better_portfolio #diversify

Viole Posted - 08/30/23

$MDGL $RXDX Got 6 bidders and went for $10.8B on positive Ph2 data in a $4.8B market. Can’t even imagine how many bidders $MDGL will get/has gotten and at what price for pending NDA in a $5.6B market with a multi-year lead on all competitors. High conviction buyout imho

Viole Posted - 08/30/23

@balzofsteel @Orkay Paul That’s ambitious, I like it. I think they’ll get bought for at least $8 billion, more hopefully $10-12.5 B. Projected revenue by 2030 is ~5.5 billion, and bios tend to get bought for at least 2x projected revenue ($RETA, $RXDX, $SGEN, etc). 6 bidders for $RXDX and it went for $10.8B with good Ph2 data in a $4.8B market. Couldn’t even imagine how many bidders $MDGL will get and at what price for pending NDA in a $5.6B market, with a multi-year lead on competitors

PennyChaser101 Posted - 08/28/23

$RXDX someone just loaded up after hours👀

ChiefThyme Posted - 7 months ago

Lets hope McKenna does for $APGE what he did for $RXDX

KazzPazz9 Posted - 8 months ago

$TSVT $APLS $DNA $RXDX

KazzPazz9 Posted - 8 months ago

$XBI $RXDX $APLS $ITOS